CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title | Date of Registration | State |
---|---|---|
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) | 28/12/2018 | Registered outdated |
Predictor of response with CIMAvax EGF© in NSCLC Phase III | 29/01/2016 | Registered |
Nimotuzumab-pancreatic cancer-adults-Phase IV. | 30/04/2017 | Registered |
Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC) | 30/04/2018 | Registered |
Nimotuzumab inoperable esophageal epithelial tumors, Phase IV | 30/06/2016 | Registered |
Itolizumab-Plasmapheresis in patients with COVID-19 | 30/06/2021 | Registered |